Ogasawara S, Yano H, Iemura A, Hisaka T, Kojiro M
First Department of Pathology, Kurume University School of Medicine, Kurume 830, Japan.
Hepatology. 1996 Jul;24(1):198-205. doi: 10.1053/jhep.1996.v24.pm0008707262.
On six human hepatocellular carcinoma (HCC) cell lines (KIM-1, KYN-1, KYN-2, KYN-3, HAK-1A, and HAK- 1B), we examined expressions and functions of the proteins and messenger RNAs (mRNAs) of basic fibroblast growth factor (bFGF) and its receptor, i.e., fibroblast growth factor receptor-1 (FGFR-1), as well as mRNA expressions of FGFR-2 approximately 4. All six cell lines expressed the proteins and mRNAs of bFGF and FGFR-1, and at least one of FGFR-2 approximately 4 mRNAs. Two of the six cell lines (KYN-1 and KYN-3) presented significant release of bFGF in culture supernatant, while the release in the remaining four cell lines was quite small. Addition of anti-bFGF neutralizing antibody (1, 10, or 20 microg/mL) to culture medium resulted in marked suppression of cell proliferation in all cell lines except HAK-1A. On the other hand, addition of exogenous bFGF (0.1, 1, or 5 ng/mL) to culture medium stimulated cell proliferation except in KIM-1 and KYN-2. When KIM-1 was transplanted to nude mice and anti-bFGF antibody was injected subcutaneously to a space surrounding the developed tumor, tumor proliferation was significantly suppressed in nude mice that received anti-bFGF antibody than in control mice, but there were no histological differences between the groups, including blood space formation in the stroma. In conclusion, hepatocellular carcinoma (HCC) cells may possess a proliferation mechanism regulated by an autocrine mechanism, a paracrine mechanism, or both, which are mediated by bFGF/FGFR.
在六种人肝癌(HCC)细胞系(KIM-1、KYN-1、KYN-2、KYN-3、HAK-1A和HAK-1B)中,我们检测了碱性成纤维细胞生长因子(bFGF)及其受体即成纤维细胞生长因子受体-1(FGFR-1)的蛋白质和信使核糖核酸(mRNA)的表达及功能,以及FGFR-2大约4种mRNA的表达。所有六种细胞系均表达bFGF和FGFR-1的蛋白质及mRNA,以及至少一种FGFR-2大约4种mRNA。六种细胞系中的两种(KYN-1和KYN-3)在培养上清液中有显著的bFGF释放,而其余四种细胞系中的释放量相当少。向培养基中添加抗bFGF中和抗体(1、10或20μg/mL)导致除HAK-1A外的所有细胞系中细胞增殖明显受到抑制。另一方面,向培养基中添加外源性bFGF(0.1、1或5 ng/mL)刺激细胞增殖,但KIM-1和KYN-2除外。当将KIM-1移植到裸鼠体内并将抗bFGF抗体皮下注射到所形成肿瘤周围的间隙时,接受抗bFGF抗体的裸鼠中的肿瘤增殖比对照小鼠显著受到抑制,但两组之间在组织学上没有差异,包括基质中的血窦形成。总之,肝癌(HCC)细胞可能具有由自分泌机制、旁分泌机制或两者介导的增殖机制,这些机制由bFGF/FGFR介导。